Soleno Therapeutics Inc — 四半期キャッシュフロー (NASDAQ:SLNO) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 330.97 M318.09 M332.31 M599.89 M563.83 M 負債合計 85.86 M85.83 M92.17 M105.09 M113.72 M 純資産合計 245.11 M232.26 M240.14 M494.81 M450.12 M 負債および純資産合計 330.97 M318.09 M332.31 M599.89 M563.83 M 有利子負債合計 49.83 M49.84 M49.84 M49.83 M49.86 M 純負債 -241.61 M-240.11 M-237 M-449.11 M-255.61 M

ニュース

Soleno Therapeutics Stock Rallies 56.4% in a Week: Here's Why

S&P500指数は停戦への期待から4営業日連続で上昇：恐怖と貪欲指数は「極度の恐怖」ゾーンにとどまる

Soleno Acquisition: Assessing The $50 Per Share Price Tag (NASDAQ:SLNO)

Wall Street Breakfast Podcast: PepsiCo Exits Kanye Fest

Neurocrine wants to develop new obesity drugs. It’s making an acquisition to accelerate that move.

M&A News: Soleno Therapeutics Stock (SLNO) Surges 28% as Neurocrine Biosciences Lines up $2.5B Deal - TipRanks.com

US stock futures edge up as investors assess Mideast ceasefire prospects

Relmada Therapeutics: 2 New Assets, 2 New 'Blockbusters'? I'd Wait And See (NASDAQ:RLMD)

AMG TimesSquare Small Cap Growth Fund Q4 2025 Performance Insights

Soleno Therapeutics、ガバナンスと法的規定を更新するため付属定款を改正

H.C. Wainwright、Soleno Therapeuticsの目標株価を100ドルに引き下げ

H.C. Wainwright cuts Soleno Therapeutics stock price target to $100